Litcius/Paper detail

Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization

Veronica Di Sarno, Gianluigi Lauro, Simona Musella, Tania Ciaglia, Vincenzo Vestuto, Marina Sala, Maria Carmina Scala, Gerardina Smaldone, Francesca Di Matteo, Sara Novi, Mario Felice Tecce, Ornella Moltedo, Giuseppe Bifulco, Pietro Campiglia, Isabel Gómez‐Monterrey, Robert Snoeck, Graciela Andreï, Carmine Ostacolo, Alessia Bertamino

2021European Journal of Medicinal Chemistry35 citationsDOIOpen Access PDF

Topics & Concepts

ProteasesIn silicoChemistryProteaseDrug discoveryVero cellProtease inhibitor (pharmacology)IC50PotencyDrug repositioningIn vitroPharmacologyDrugComputational biologyEnzymeBiochemistryVirologyBiologyVirusViral loadAntiretroviral therapyGeneSARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks ResearchMosquito-borne diseases and control
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization | Litcius